unichem lab. ltd. presentation
TRANSCRIPT
![Page 1: Unichem lab. ltd. presentation](https://reader033.vdocuments.us/reader033/viewer/2022051520/58a26d681a28ab94628b4ea5/html5/thumbnails/1.jpg)
Touching Human Lives
![Page 2: Unichem lab. ltd. presentation](https://reader033.vdocuments.us/reader033/viewer/2022051520/58a26d681a28ab94628b4ea5/html5/thumbnails/2.jpg)
CONTENT
![Page 3: Unichem lab. ltd. presentation](https://reader033.vdocuments.us/reader033/viewer/2022051520/58a26d681a28ab94628b4ea5/html5/thumbnails/3.jpg)
OUR VISION
![Page 4: Unichem lab. ltd. presentation](https://reader033.vdocuments.us/reader033/viewer/2022051520/58a26d681a28ab94628b4ea5/html5/thumbnails/4.jpg)
OUR GLOBAL REACH
INDIA
UK
USA
CANADA
SOUTH AFRICA
BRAZIL GHANA
RUSSIA
UKRAINE
21 US ANDA
APPROVED
800+ Product
Registration Worldwide
Asia Pac, 46%
Africa, 43%
Latin America,
7%
Russia/ CIS, 4%
Emerging Market
US / CANADA,
65%
EUROPE, 35%
Regulated Market
![Page 5: Unichem lab. ltd. presentation](https://reader033.vdocuments.us/reader033/viewer/2022051520/58a26d681a28ab94628b4ea5/html5/thumbnails/5.jpg)
OUR PRODUCTS
200+ Products
#1 in 17
Therapeutic groups
Top 5 in 69
Therapeutic groups
CNS
ACUTE
CARDIO/DIABETO
![Page 6: Unichem lab. ltd. presentation](https://reader033.vdocuments.us/reader033/viewer/2022051520/58a26d681a28ab94628b4ea5/html5/thumbnails/6.jpg)
OUR CORPORATE SOCIAL RESPONSIBILITY
• Adiwasi Unnati Mandal - Changing Lives of Tribal People
• Amrut Mody School of Management – Top Educational Institute
• Vision Foundation of India – Providing Vision
• Muktangan - Educating underprivileged children
![Page 7: Unichem lab. ltd. presentation](https://reader033.vdocuments.us/reader033/viewer/2022051520/58a26d681a28ab94628b4ea5/html5/thumbnails/7.jpg)
OUR RESULTS
10
5 1
10
12
4
2013-14 2014-15 2015-16
GROSS SALES (IN INR CRORES)
GROSS SALES
PAT
EPS
INR11/share
INR124crores INR10crores
DIVIDEND
INR2/share
![Page 8: Unichem lab. ltd. presentation](https://reader033.vdocuments.us/reader033/viewer/2022051520/58a26d681a28ab94628b4ea5/html5/thumbnails/8.jpg)
OUR FUTURE
• Focus on Development of Novel Drug Delivery System and patent non-infringing processes for APIS
• 5% Revenue spend on R&D
• Leveraging Growth in Developed Markets to Emerging Markets
• Focus remains on increasing customer base, market share and productivity